Send us a textThis episode is part two of our show with Mark Farmery, founder of Biotech Bikers and Chief Development Officer at Swedish biotech firm, Anocca. In part II Mark tells us about how his urge to apply scientific education led him from academia into pharma and biotech business development. Mark also explains biotech venture basics, as well as the T cell therapies his employer, Anocca, is pioneering to address pancreatic cancer, which is usually fatal. Stay tuned to learn quite a bit, as the subject matter ranges far from our well worn topics, and check out part I to hear about how Mark founded an international network of Biotech Bikers.Mark Farmery:https://www.linkedin.com/in/markfarmeryAnocca:https://www.anocca.com/ChaptersMark's Journey: From England to SwedenUnderstanding Microbiology and BiochemistryTransitioning from Academia to IndustryThe Role of Pharmaceuticals in HealthcareAstraZeneca: Navigating the Patent CliffThe Power of Collaboration in BiotechTransitioning to Business DevelopmentUnderstanding Pharmaceutical R&D ChallengesThe Biotech Venture Model ExplainedInnovations in T Cell TherapiesAnocca's Clinical Trial MilestoneRole of Chief Development Officer at AnoccaHill Climbers is more than just a podcast, it's a growing business network for cyclists. You can tap into our event by following our Linkedin and Instagram, and subscribing to our newsletter. Startuplandia.io Sponsors Hill Climbers Content & Free Beer www.hill-climbers.comInstagramLinkedinTheme Music: Summer Vibes by Rizik

Ver todos los episodios